Sec Form 4 Filing - Borchers Bob @ Dolby Laboratories, Inc. - 2017-11-15

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
Borchers Bob
2. Issuer Name and Ticker or Trading Symbol
Dolby Laboratories, Inc. [ DLB]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
SVP & Chief Marketing Officer
(Last) (First) (Middle)
C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET
3. Date of Earliest Transaction (MM/DD/YY)
11/15/2017
(Street)
SAN FRANCISCO, CA94103
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 11/15/2017 M 26,354 A $ 33.15 76,455 ( 1 ) ( 2 ) D
Class A Common Stock 11/15/2017 S 26,354 D $ 61.0025 ( 3 ) 50,101 ( 1 ) ( 2 ) D
Class A Common Stock 11/15/2017 M 23,646 A $ 41.31 73,747 ( 1 ) ( 2 ) D
Class A Common Stock 11/15/2017 S 23,646 D $ 61.0025 ( 3 ) 50,101 ( 1 ) ( 2 ) D
Class A Common Stock 11/16/2017 M 16,821 A $ 41.31 66,922 ( 1 ) ( 2 ) D
Class A Common Stock 11/16/2017 S 16,821 D $ 61.0904 ( 4 ) 50,101 ( 1 ) ( 2 ) D
Class A Common Stock 11/17/2017 M 50,000 D $ 41.31 100,101 ( 1 ) ( 2 ) D
Class A Common Stock 11/17/2017 S 50,000 D $ 61.3235 ( 5 ) 50,101 ( 1 ) ( 2 ) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) $ 33.15 11/15/2017 M 26,354 ( 6 ) 12/15/2025 Class A Common Stock 26,354 $ 0 28,646 D
Employee Stock Option (right to buy) $ 41.31 11/15/2017 M 23,646 ( 7 ) 01/15/2024 Class A Common Stock 23,646 $ 0 195,404 D
Employee Stock Option (right to buy) $ 41.31 11/16/2017 M 16,821 ( 7 ) 01/15/2024 Class A Common Stock 16,821 $ 0 178,583 D
Employee Stock Option (right to buy) $ 41.31 11/17/2017 M 50,000 ( 7 ) 01/15/2014 Class A Common Stock 50,000 $ 0 128,583 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Borchers Bob
C/O DOLBY LABORATORIES, INC.
1275 MARKET STREET
SAN FRANCISCO, CA94103
SVP & Chief Marketing Officer
Signatures
/s/ Daniel Rodriguez, Attorney-in-Fact for Bob Borchers 11/17/2017
Signature of Reporting Person Date
Explanation of Responses:
( 1 )Shares held following the reported transactions include 40,748 restricted stock units, which are subject to forfeiture until they vest.
( 2 )Shares include 526 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2017.
( 3 )This transaction was executed in multiple trades at prices ranging from $61 to $61.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
( 4 )This transaction was executed in multiple trades at prices ranging from $61 to $61.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
( 5 )This transaction was executed in multiple trades at prices ranging from $61.31 to $61.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
( 6 )This option was granted for a total of 55,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2015, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter.
( 7 )This option was granted for a total of 171,425 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of January 15, 2014, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.